Influence of host resistance on viral adaptation: hepatitis C virus as a case study

References

• AlterHJSeeffLBRecovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcomeSemin Liver Dis2000201173510895429
   PubMed Web of Science ®Google Scholar
• ChisariFVUnscrambling hepatitis C virus-host interactionsNature2005436705393093216107831
   PubMed Web of Science ®Google Scholar
• TanSLHepatitis C Viruses: Genomes and Molecular BiologyAbingdon, UKTaylor and Francis2006
   Google Scholar
• LokASSeeffLBMorganTRIncidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseGastroenterology2009136113814818848939
   PubMed Web of Science ®Google Scholar
• SeeffLBThe history of the “natural history” of hepatitis C (1968–2009)Liver Int200929Suppl 1899919207971
   PubMed Web of Science ®Google Scholar
• FabrySNarasimhanRA100 Questions and Answers About Hepatitis C: A Lahey Clinic GuideSudbury (MA)Jones and Bartlett2006
   Google Scholar
• ChooQLKuoGWeinerAJOverbyLRBradleyDWHoughtonMIsolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genomeScience198924449023593622523562
   PubMed Web of Science ®Google Scholar
• NelsonPKMathersBMCowieBGlobal epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsLancet2011378979157158321802134
   PubMed Web of Science ®Google Scholar
• GrebelyJDoreGJWhat is killing people with hepatitis C virus infection?Semin Liver Dis201131433133922189973
   PubMed Web of Science ®Google Scholar
• GrebelyJDoreGJCan hepatitis C virus infection be eradicated in people who inject drugs?Antiviral Res2014104627224468275
   PubMed Web of Science ®Google Scholar
• LavanchyDEvolving epidemiology of hepatitis C virusClin Microbiol Infect201117210711521091831
   PubMed Web of Science ®Google Scholar
• ThurszMFontanetAHCV transmission in industrialized countries and resource-constrained areasNat Rev Gastroenterol Hepatol2014111283524080775
   PubMed Web of Science ®Google Scholar
• GradyBPPrinsMvan der LoeffMSThe sexual transmission rate of HCV among heterosexual couplesHepatology20135851865186623424089
   PubMed Web of Science ®Google Scholar
• TerraultNADodgeJLMurphyELSexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners studyHepatology201357388188923175457
   PubMed Web of Science ®Google Scholar
• GentileIZappuloEBuonomoARBorgiaGPrevention of mother-to-child transmission of hepatitis B virus and hepatitis C virusExpert Rev Anti Infect Ther201412777578224840817
   PubMed Web of Science ®Google Scholar
• MurakamiJNagataIIitsukaTRisk factors for mother-to-child transmission of hepatitis C virus: maternal high viral load and fetal exposure in the birth canalHepatol Res201242764865722404371
   PubMed Web of Science ®Google Scholar
• SanjuanRNebotMRChiricoNManskyLMBelshawRViral mutation ratesJ Virol201084199733974820660197
   PubMed Web of Science ®Google Scholar
• DiamondMSEvasion of innate and adaptive immunity by flavivirusesImmunol Cell Biol200381319620612752684
   PubMed Web of Science ®Google Scholar
• FishmanSLBranchADThe quasispecies nature and biological implications of the hepatitis C virusInfect Genet Evol2009961158116719666142
   PubMed Web of Science ®Google Scholar
• SimmondsPGenetic diversity and evolution of hepatitis C virus – 15 years onJ Gen Virol200485Pt 113173318815483230
   PubMed Web of Science ®Google Scholar
• SmithDBBukhJKuikenCExpanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resourceHepatology201459131832724115039
   PubMed Web of Science ®Google Scholar
• JirilloEHepatitis C Virus Disease: Immunobiology and Clinical ApplicationsHeidelbergSpringer2007
   Google Scholar
• WeinerAJChristophersonCHallJESequence variation in hepatitis C viral isolatesJ Hepatol199113Suppl 4S6S141668332
   PubMed Web of Science ®Google Scholar
• FornsXPurcellRHBukhJQuasispecies in viral persistence and pathogenesis of hepatitis C virusTrends Microbiol199971040241010498948
   PubMed Web of Science ®Google Scholar
• FarciPShimodaAWongDPrevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 proteinProc Natl Acad Sci U S A1996932615394153998986822
   PubMed Web of Science ®Google Scholar
• ZibertAKraasWMeiselHJungGRoggendorfMEpitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virusJ Virol1997715412341279094694
   PubMed Web of Science ®Google Scholar
• DowdKANetskiDMWangXHCoxALRaySCSelection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virusGastroenterology200913672377238619303013
   PubMed Web of Science ®Google Scholar
• RauchAGaudieriSThioCBochudPYHost genetic determinants of spontaneous hepatitis C clearancePharmacogenomics200910111819183719891557
   PubMed Web of Science ®Google Scholar
• KärreKHow to recognize a foreign submarineImmunol Rev19971551599059878
   PubMed Web of Science ®Google Scholar
• JanewayCAJrApproaching the asymptote? Evolution and revolution in immunologyCold Spring Harb Symp Quant Biol198954Pt 11132700931
   PubMedGoogle Scholar
• JanewayCAJrThe immune system evolved to discriminate infectious nonself from noninfectious selfImmunol Today199213111161739426
   PubMedGoogle Scholar
• GaleMJrFoyEMEvasion of intracellular host defence by hepatitis C virusNature2005436705393994516107833
   PubMed Web of Science ®Google Scholar
• ThimmeRLohmannVWeberFA target on the move: innate and adaptive immune escape strategies of hepatitis C virusAntiviral Res200669312914116413618
   PubMed Web of Science ®Google Scholar
• SuAIPezackiJPWodickaLGenomic analysis of the host response to hepatitis C virus infectionProc Natl Acad Sci U S A20029924156691567412441396
   PubMed Web of Science ®Google Scholar
• ChenLBorozanIFeldJHepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infectionGastroenterology200512851437144415887125
   PubMed Web of Science ®Google Scholar
• FeldJJNandaSHuangYHepatic gene expression during treatment with peginterferon and ribavirin: identifying molecular pathways for treatment responseHepatology20074651548156317929300
   PubMed Web of Science ®Google Scholar
• Sarasin-FilipowiczMOakeleyEJDuongFHInterferon signaling and treatment outcome in chronic hepatitis CProc Natl Acad Sci U S A2008105197034703918467494
   PubMed Web of Science ®Google Scholar
• JanewayCAJrMedzhitovRInnate immune recognitionAnnu Rev Immunol20022019721611861602
   PubMed Web of Science ®Google Scholar
• HallerOWeberFPathogenic viruses: smart manipulators of the interferon systemCurr Top Microbiol Immunol200731631533417969454
   PubMed Web of Science ®Google Scholar
• WilliamsBRPKR; a sentinel kinase for cellular stressOncogene199918456112612010557102
   PubMed Web of Science ®Google Scholar
• SadlerAJWilliamsBRInterferon-inducible antiviral effectorsNat Rev Immunol20088755956818575461
   PubMed Web of Science ®Google Scholar
• KumarMCarmichaelGGAntisense RNA: function and fate of duplex RNA in cells of higher eukaryotesMicrobiol Mol Biol Rev1998624141514349841677
   PubMed Web of Science ®Google Scholar
• SamuelCEAntiviral actions of interferonsClin Microbiol Rev200114477880911585785
   PubMed Web of Science ®Google Scholar
• HolzingerDJornsCStertzSInduction of MxA gene expression by influenza A virus requires type I or type III interferon signalingJ Virol200781147776778517494065
   PubMed Web of Science ®Google Scholar
• TanakaYNishidaNSugiyamaMGenome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis CNat Genet200941101105110919749757
   PubMed Web of Science ®Google Scholar
• SuppiahVMoldovanMAhlenstielGIL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapyNat Genet200941101100110419749758
   PubMed Web of Science ®Google Scholar
• GeDFellayJThompsonAJGenetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature2009461726239940119684573
   PubMed Web of Science ®Google Scholar
• RauchAKutalikZDescombesPGenetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyGastroenterology20101384133813451345.e1e720060832
   PubMed Web of Science ®Google Scholar
• ThomasDLThioCLMartinMPGenetic variation in IL28B and spontaneous clearance of hepatitis C virusNature2009461726579880119759533
   PubMed Web of Science ®Google Scholar
• ThompsonAJMuirAJSulkowskiMSInterleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virusGastroenterology20101391120129.e1820399780
   PubMed Web of Science ®Google Scholar
• Prokunina-OlssonLMuchmoreBTangWA variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusNat Genet201345216417123291588
   PubMed Web of Science ®Google Scholar
• LangeCMZeuzemSIL28B single nucleotide polymorphisms in the treatment of hepatitis CJ Hepatol201155369270121440591
   PubMed Web of Science ®Google Scholar
• McFarlandAPHornerSMJarretAThe favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAsNat Immunol2014151727924241692
   PubMed Web of Science ®Google Scholar
• ChinnaswamySChatterjeeSBoopathiRMukherjeeSBhattacharjeeSKunduTKA single nucleotide polymorphism associated with hepatitis C virus infections located in the distal region of the IL28B promoter influences NF-κB-mediated gene transcriptionPloS One2013810e7549524116050
   PubMed Web of Science ®Google Scholar
• KärreKLjunggrenHGPiontekGKiesslingRSelective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategyNature198631960556756783951539
   PubMed Web of Science ®Google Scholar
• NielsenNØdumNUrsøBLanierLLSpeePCytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2APloS One201272e3195922384114
   PubMed Web of Science ®Google Scholar
• PeppaDGillUSReynoldsGUp-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletionJ Exp Med201321019911423254287
   PubMed Web of Science ®Google Scholar
• FieldsBNKnipeDMHowleyPMFields Virology1PhiladelphiaLippincott Williams & Wilkins2007
   Google Scholar
• PaulWEFundamental ImmunologyPhiladelphiaLippincott Williams and Wilkins2008
   Google Scholar
• JamilKMKhakooSIKIR/HLA interactions and pathogen immunityJ Biomed Biotechnol2011201129834821629750
   PubMedGoogle Scholar
• WilsonMJTorkarMHaudeAPlasticity in the organization and sequences of human KIR/ILT gene familiesProc Natl Acad Sci U S A20009794778478310781084
   PubMed Web of Science ®Google Scholar
• TrowsdaleJGenetic and functional relationships between MHC and NK receptor genesImmunity200115336337411567627
   PubMed Web of Science ®Google Scholar
• ParhamPAbi-RachedLMatevosyanLPrimate-specific regulation of natural killer cellsJ Med Primatol201039419421220618586
   PubMed Web of Science ®Google Scholar
• HershbergerKLShyamRMiuraALetvinNLDiversity of the killer cell Ig-like receptors of rhesus monkeysJ Immunol200116674380439011254692
   PubMed Web of Science ®Google Scholar
• KhakooSIRajalingamRShumBPRapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humansImmunity200012668769810894168
   PubMed Web of Science ®Google Scholar
• UhrbergMValianteNMShumBPHuman diversity in killer cell inhibitory receptor genesImmunity1997767537639430221
   PubMed Web of Science ®Google Scholar
• DringMMMorrisonMHMcSharryBPInnate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infectionProc Natl Acad Sci U S A2011108145736574121402922
   PubMed Web of Science ®Google Scholar
• MartinMPGaoXLeeJHEpistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDSNat Genet200231442943412134147
   PubMed Web of Science ®Google Scholar
• KhakooSIThioCLMartinMPHLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infectionScience2004305568587287415297676
   PubMed Web of Science ®Google Scholar
• RajagopalanSLongEOUnderstanding how combinations of HLA and KIR genes influence diseaseJ Exp Med200520171025102915809348
   PubMed Web of Science ®Google Scholar
• GershwinEVierlingJMMannsMPLiver Immunology: Principles and PracticeNew YorkHumana2007
   Google Scholar
• DiepolderHMZachovalRHoffmannRMPossible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infectionLancet19953468981100610077475549
   PubMed Web of Science ®Google Scholar
• GerlachJTDiepolderHMJungMCRecurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis CGastroenterology1999117493394110500077
   PubMed Web of Science ®Google Scholar
• MissaleGBertoniRLamonacaVDifferent clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune responseJ Clin Invest19969837067148698862
   PubMed Web of Science ®Google Scholar
• LechnerFWongDKDunbarPRAnalysis of successful immune responses in persons infected with hepatitis C virusJ Exp Med200019191499151210790425
   PubMed Web of Science ®Google Scholar
• TakakiAWieseMMaertensGCellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis CNat Med20006557858210802716
   PubMed Web of Science ®Google Scholar
• ThimmeROldachDChangKMSteigerCRaySCChisariFVDeterminants of viral clearance and persistence during acute hepatitis C virus infectionJ Exp Med2001194101395140611714747
   PubMed Web of Science ®Google Scholar
• ThimmeRBukhJSpangenbergHCViral and immunological determinants of hepatitis C virus clearance, persistence, and diseaseProc Natl Acad Sci U S A20029924156611566812441397
   PubMed Web of Science ®Google Scholar
• DayCLLauerGMRobbinsGKBroad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infectionJ Virol20027624125841259512438584
   PubMed Web of Science ®Google Scholar
• GrunerNHGerlachTJJungMCAssociation of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis CJ Infect Dis200018151528153610823750
   PubMed Web of Science ®Google Scholar
• CooperSEricksonALAdamsEJAnalysis of a successful immune response against hepatitis C virusImmunity199910443944910229187
   PubMed Web of Science ®Google Scholar
• DalodMDupuisMDescheminJCWeak anti-HIV CD8(+) T-cell effector activity in HIV primary infectionJ Clin Invest1999104101431143910562305
   PubMed Web of Science ®Google Scholar
• BattegayMFikesJDi BisceglieAMPatients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 moleculesJ Virol1995694246224707884894
   PubMed Web of Science ®Google Scholar
• CernyAMcHutchisonJGPasquinelliCCytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motifJ Clin Invest19959525215307860734
   PubMed Web of Science ®Google Scholar
• ChangKMThimmeRMelpolderJJDifferential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infectionHepatology200133126727611124845
   PubMed Web of Science ®Google Scholar
• FerrariCValliAGalatiLT-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infectionsHepatology19941922862958294086
   PubMed Web of Science ®Google Scholar
• KozielMJDudleyDAfdhalNHLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine releaseJ Clin Invest1995965231123217593618
   PubMed Web of Science ®Google Scholar
• WongDKDudleyDDDohrenwendPBDetection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCVJ Virol20017531229123511152496
   PubMed Web of Science ®Google Scholar
• LauerGMOuchiKChungRTComprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificitiesJ Virol200276126104611312021343
   PubMed Web of Science ®Google Scholar
• KozielMJDudleyDAfdhalNHepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCVJ Virol19936712752275327693974
   PubMed Web of Science ®Google Scholar
• RehermannBChangKMMcHutchinsonJDifferential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patientsJ Virol19967010709271028794355
   PubMed Web of Science ®Google Scholar
• Neumann-HaefelinCBlumHEChisariFVThimmeRT cell response in hepatitis C virus infectionJ Clin Virol2005322758515653409
   PubMed Web of Science ®Google Scholar
• LiKFoyEFerreonJCImmune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIFProc Natl Acad Sci U S A200510282992299715710891
   PubMed Web of Science ®Google Scholar
• FoyELiKSumpterRJrControl of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signalingProc Natl Acad Sci U S A200510282986299115710892
   PubMed Web of Science ®Google Scholar
• FoyELiKWangCRegulation of interferon regulatory factor-3 by the hepatitis C virus serine proteaseScience200330056221145114812702807
   PubMed Web of Science ®Google Scholar
• VilascoMLarreaEVitourDThe protein kinase IKKε can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected liversHepatology20064461635164717133498
   PubMed Web of Science ®Google Scholar
• JohnsonCLOwenDMGaleMJrFunctional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defenseJ Biol Chem200728214107921080317289677
   PubMed Web of Science ®Google Scholar
• BinderMKochsGBartenschlagerRLohmannVHepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategyHepatology20074651365137417668876
   PubMed Web of Science ®Google Scholar
• MeylanECurranJHofmannKCardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature200543770621167117216177806
   PubMed Web of Science ®Google Scholar
• GaleMJrBlakelyCMKwieciszewskiBControl of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulationMol Cell Biol1998189520852189710605
   PubMed Web of Science ®Google Scholar
• TaylorDRShiSTRomanoPRBarberGNLaiMMInhibition of the interferon-inducible protein kinase PKR by HCV E2 proteinScience1999285542410711010390359
   PubMed Web of Science ®Google Scholar
• GaleMJJrKorthMJTangNMEvidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A proteinVirology199723022172279143277
   PubMed Web of Science ®Google Scholar
• BodeJGLudwigSEhrhardtCIFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3FASEB J200317348849012551851
   PubMed Web of Science ®Google Scholar
• MelénKFagerlundRNyqvistMKeskinenPJulkunenIExpression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATsJ Med Virol200473453654715221897
   PubMed Web of Science ®Google Scholar
• LinWKimSSYeungEHepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domainJ Virol200680189226923516940534
   PubMed Web of Science ®Google Scholar
• KawamuraHGovindarajanSAswadFHCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in miceHepatology200644493694417006910
   PubMed Web of Science ®Google Scholar
• LinWChoeWHHiasaYHepatitis C virus expression suppresses interferon signaling by degrading STAT1Gastroenterology200512841034104115825084
   PubMed Web of Science ®Google Scholar
• MiyamotoHMoriishiKMoriyaKInvolvement of the PA28γ-dependent pathway in insulin resistance induced by hepatitis C virus core proteinJ Virol20078141727173517135326
   PubMed Web of Science ®Google Scholar
• KhuYLTanYJLimSGHongWGohPYHepatitis C virus nonstructural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activityBiochem J2004384Pt 240140915303969
   PubMed Web of Science ®Google Scholar
• OsnaNAHepatitis C virus and ethanol alter antigen presentation in liver cellsWorld J Gastroenterol200915101201120819291820
   PubMed Web of Science ®Google Scholar
• HerzerKFalkCSEnckeJUpregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicityJ Virol200377158299830912857899
   PubMed Web of Science ®Google Scholar
• CohenGBGandhiRTDavisDMThe selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cellsImmunity199910666167110403641
   PubMed Web of Science ®Google Scholar
• KimHMazumdarBBoseSKHepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surfaceJ Virol201286189919992822761382
   PubMed Web of Science ®Google Scholar
• Schulze Zur WieschJCiuffredaDLewis-XimenezLBroadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistenceJ Exp Med20122091617522213804
   PubMed Web of Science ®Google Scholar
• LucasMUlsenheimerAPfafferotKTracking virus-specific CD4+ T cells during and after acute hepatitis C virus infectionPloS One200727e64917653276
   PubMed Web of Science ®Google Scholar
• KlenermanPMcMichaelAAIDS/HIV. Finding footprints among the treesScience200731558181505150717363650
   PubMed Web of Science ®Google Scholar
• GaudieriSRauchAParkLPEvidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infectionJ Virol20068022110941110417071929
   PubMed Web of Science ®Google Scholar
• RauchAJamesIPfafferottKDivergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressureHepatology20095041017102919670417
   PubMed Web of Science ®Google Scholar
• MooreCBJohnMJamesIRChristiansenFTWittCSMallalSAEvidence of HIV-1 adaptation to HLA-restricted immune responses at a population levelScience200229655721439144312029127
   PubMed Web of Science ®Google Scholar
• BullRALucianiFMcElroyKSequential bottlenecks drive viral evolution in early acute hepatitis C virus infectionPLoS Pathog201179e100224321912520
   PubMed Web of Science ®Google Scholar
• LeslieAKavanaghDHoneyborneITransmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLAJ Exp Med2005201689190215781581
   PubMed Web of Science ®Google Scholar
• MeraniSPetrovicDJamesIEffect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreakHepatology201153239640521246583
   PubMed Web of Science ®Google Scholar
• Neumann-HaefelinCMcKiernanSWardSDominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolutionHepatology200643356357216496339
   PubMed Web of Science ®Google Scholar
• RaySCFanningLWangXHNetskiDMKenny-WalshEThomasDLDivergent and convergent evolution after a common-source outbreak of hepatitis C virusJ Exp Med2005201111753175915939791
   PubMed Web of Science ®Google Scholar
• FitzmauriceKPetrovicDRamamurthyNMolecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infectionGut201160111563157121551190
   PubMed Web of Science ®Google Scholar
• KimAYKuntzenTTimmJSpontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopesGastroenterology20111402686696.e120875418
   PubMed Web of Science ®Google Scholar
• AllenTMAltfeldMGeerSCSelective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolutionJ Virol20057921132391324916227247
   PubMed Web of Science ®Google Scholar
• FriedrichTCDoddsEJYantLJReversion of CTL escape-variant immunodeficiency viruses in vivoNat Med200410327528114966520
   PubMed Web of Science ®Google Scholar
• HerbeckJTNickleDCLearnGHHuman immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new hostJ Virol20068041637164416439520
   PubMed Web of Science ®Google Scholar
• LeslieAJPfafferottKJChettyPHIV evolution: CTL escape mutation and reversion after transmissionNat Med200410328228914770175
   PubMed Web of Science ®Google Scholar
• CoxALMosbrugerTMaoQCellular immune selection with hepatitis C virus persistence in humansJ Exp Med2005201111741175215939790
   PubMed Web of Science ®Google Scholar
• KuntzenTTimmJBericalAViral sequence evolution in acute hepatitis C virus infectionJ Virol20078121116581166817699568
   PubMed Web of Science ®Google Scholar
• PfafferottKGaudieriSUlsenheimerAConstrained pattern of viral evolution in acute and early HCV infection limits viral plasticityPloS One201162e1679721347433
   PubMed Web of Science ®Google Scholar
• AlterGHeckermanDSchneidewindAHIV-1 adaptation to NK-cell-mediated immune pressureNature201147673589610021814282
   PubMed Web of Science ®Google Scholar
• MartellMEstebanJIQuerJHepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distributionJ Virol1992665322532291313927
   PubMed Web of Science ®Google Scholar
• FarciPBukhJPurcellRHThe quasispecies of hepatitis C virus and the host immune responseSpringer Semin Immunopathol19971915269266628
   PubMed Web of Science ®Google Scholar
• ManzinASolforosiLClementiMDynamics of viral quasispecies in hepatitis C virus infectionRes Virol199714821711769108621
   PubMedGoogle Scholar
• FarciPShimodaACoianaAThe outcome of acute hepatitis C predicted by the evolution of the viral quasispeciesScience2000288546433934410764648
   PubMed Web of Science ®Google Scholar
• WohnslandAHofmannWPSarrazinCViral determinants of resistance to treatment in patients with hepatitis CClin Microbiol Rev2007201233817223621
   PubMed Web of Science ®Google Scholar
• EnomotoNSakumaIAsahinaYComparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A regionJ Clin Invest19959612242307542279
   PubMed Web of Science ®Google Scholar
• EnomotoNSakumaIAsahinaYMutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infectionN Engl J Med1996334277818531962
   PubMed Web of Science ®Google Scholar
• LinCGatesCARaoBGIn vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061J Biol Chem200528044367843679116087668
   PubMed Web of Science ®Google Scholar
• LinCLinKLuongYPIn vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanismsJ Biol Chem200427917175081751414766754
   PubMed Web of Science ®Google Scholar
• SarrazinCKiefferTLBartelsDDynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevirGastroenterology200713251767177717484874
   PubMed Web of Science ®Google Scholar
• ApplegateTLGaudieriSPlauzollesANaturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis CAntivir Ther Epub August 8, 2014
   Web of Science ®Google Scholar
• JohnMMooreCBJamesIRMallalSAInteractive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1Antivir Ther200510455155516038481
   PubMed Web of Science ®Google Scholar
• MuellerSMSchaetzBEismannKDual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 proteaseJ Virol20078162887289817202219
   PubMed Web of Science ®Google Scholar
• SalloumSKlugeSFKimAYRoggendorfMTimmJThe resistance mutation R155K in the NS3/4A protease of hepatitis C virus also leads the virus to escape from HLA-A*68-restricted CD8 T cellsAntiviral Res201087227227520488208
   PubMed Web of Science ®Google Scholar
• GaudieriSRauchAPfafferottKHepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapyHepatology20094941069108219263475
   PubMed Web of Science ®Google Scholar
• SchaeferEAChungRTAnti-hepatitis C virus drugs in developmentGastroenterology2012142613401350.e122537441
   PubMed Web of Science ®Google Scholar
• JanssenHLReesinkHWLawitzEJTreatment of HCV infection by targeting microRNAN Engl J Med2013368181685169423534542
   PubMed Web of Science ®Google Scholar
• LanfordREHildebrandt-EriksenESPetriATherapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infectionScience2010327596219820119965718
   PubMed Web of Science ®Google Scholar
• WendtABourlièreMAn update on the treatment of genotype-1 chronic hepatitis C infection: lessons from recent clinical trialsTher Adv Infect Dis20131619120825165553
   PubMedGoogle Scholar
• Hepatitis C Virus (HCV) Database Project [database on the Internet]Los Alamos National Security Available from: http://hcv.lanl.gov/content/indexAccessed January 8, 2015
   Google Scholar